Loading provider…
Loading provider…
Hematology & Oncology Physician in Providence, RI
NPI: 1467459263Primary Practice Location
ROGER WILLIAMS MEDICAL CENTER
825 Chalkstone Ave, Providence, RI
Primary Employer
Roger Williams Medical Center
chartercare.org
HQ Phone
Get MD Ritesh's Phone Numberphone_androidMobile
Get MD Ritesh's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardRI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 163 | 489 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 29 | 34 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 27 | 27 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 22 | 121 |
Sotorasib as Fourth-Line Treatment in Pancreatic Cancer: A Case Report and Literature Review.
Authors: Ifeanyichukwu Onukogu, Georgio Medawar
Journal: R I Med J (2013)
Publication Date: 2024-07-01
Adequate lymph node evaluation in the elderly is associated with improved survival in patients with stage I-III colon cancer: A validation study using the National Cancer Data Base.
Authors: Jeffrey Reha
Publication Date: 2017-08-17
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Nivolumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, PROCEDURE: Computed Tomography, PROCEDURE: Echocardiography Test, OTHER: Observation Activity
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Clinical Observation, OTHER: Placebo Administration, DRUG: Erlotinib Hydrochloride
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, BIOLOGICAL: Nivolumab, BIOLOGICAL: Pembrolizumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, OTHER: Clinical Observation, DRUG: Gemcitabine Hydrochloride, DRUG: Crizotinib, DRUG: Paclitaxel, OTHER: Placebo Administration, PROCEDURE: Computed Tomography, DRUG: Erlotinib, DRUG: Pemetrexed, DRUG: Pemetrexed Disodium, OTHER: Cytology Specimen Collection Procedure, PROCEDURE: Echocardiography Test